LobbyingCelltrion USA lobbying by quarter
See every registered agent of the Korean government
Celltrion USA's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2024; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Celltrion USA
Celltrion group
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 6 reports
- Medical research and clinical labs$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Bluebird Strategies | $0 | 7 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/06for Q2 | Bluebird Strategies | Under $5,000 |
| 04/06for Q1 | Bluebird Strategies | Under $5,000 |
| 01/21for Q4 2025 | Bluebird Strategies | Under $5,000 |
| 25/11/09for Q3 2025 | Bluebird Strategies | Under $5,000 |
| 25/07/28for Q2 2025 | Bluebird Strategies | Under $5,000 |
| 25/04/23for Q1 2025 | Bluebird Strategies | Under $5,000 |
| 25/01/20for Q4 2024 | Bluebird Strategies | Under $5,000 |
| 24/10/17for Q4 2024 | Bluebird Strategies | Under $5,000 |